Your Article Summary
Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
Watson Pharmaceuticals, 07/13/09
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it has resumed shipments to reintroduce its intravenous iron replacement therapy INFeD. The product, which had been out of stock due to changes in the final product manufacturing site and issues with raw material supply, is re-entering the market earlier than expected. Watson expects to be in a normal supply situation for INFeD shortly.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09
A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09
Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09
Article Search
Sponsor


See Latest Articles


